628 related articles for article (PubMed ID: 9601040)
21. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex.
Vinitsky A; Michaud C; Powers JC; Orlowski M
Biochemistry; 1992 Oct; 31(39):9421-8. PubMed ID: 1356435
[TBL] [Abstract][Full Text] [Related]
22. Sodium dodecyl sulfate (SDS) activation of the 20S proteasome in rat liver.
Shibatani T; Ward WF
Arch Biochem Biophys; 1995 Aug; 321(1):160-6. PubMed ID: 7639516
[TBL] [Abstract][Full Text] [Related]
23. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.
Ostrowska H; Wojcik C; Omura S; Worowski K
Biochem Biophys Res Commun; 1997 May; 234(3):729-32. PubMed ID: 9175783
[TBL] [Abstract][Full Text] [Related]
24. Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the "immunoproteasome".
Cardozo C; Kohanski RA
J Biol Chem; 1998 Jul; 273(27):16764-70. PubMed ID: 9642232
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the active site of human multicatalytic proteinase.
Mason RW
Biochem J; 1990 Jan; 265(2):479-84. PubMed ID: 2302179
[TBL] [Abstract][Full Text] [Related]
26. Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells.
Gardner RC; Assinder SJ; Christie G; Mason GG; Markwell R; Wadsworth H; McLaughlin M; King R; Chabot-Fletcher MC; Breton JJ; Allsop D; Rivett AJ
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):447-54. PubMed ID: 10677365
[TBL] [Abstract][Full Text] [Related]
27. Peptidase activities of the multicatalytic protease in rat liver after voluntary and intragastric ethanol administration.
Donohue TM; Zetterman RK; Zhang-Gouillon ZQ; French SW
Hepatology; 1998 Aug; 28(2):486-91. PubMed ID: 9696015
[TBL] [Abstract][Full Text] [Related]
28. Purification and characterization of Candida albicans 20S proteasome: identification of four proteasomal subunits.
Fernández Murray P; Biscoglio MJ; Passeron S
Arch Biochem Biophys; 2000 Mar; 375(2):211-9. PubMed ID: 10700377
[TBL] [Abstract][Full Text] [Related]
29. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.
Harding CV; France J; Song R; Farah JM; Chatterjee S; Iqbal M; Siman R
J Immunol; 1995 Aug; 155(4):1767-75. PubMed ID: 7636233
[TBL] [Abstract][Full Text] [Related]
30. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
Goasduff T; Cederbaum AI
Arch Biochem Biophys; 2000 Jul; 379(2):321-30. PubMed ID: 10898951
[TBL] [Abstract][Full Text] [Related]
31. The multicatalytic proteinase (proteasome) of the hawkmoth, Manduca sexta: catalytic properties and immunological comparison with the lobster enzyme complex.
Haire MF; Clark JJ; Jones ME; Hendil KB; Schwartz LM; Mykles DL
Arch Biochem Biophys; 1995 Apr; 318(1):15-24. PubMed ID: 7726556
[TBL] [Abstract][Full Text] [Related]
32. Proteolytic mechanisms underlying mitochondrial degradation in the ocular lens.
Zandy AJ; Bassnett S
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):293-302. PubMed ID: 17197546
[TBL] [Abstract][Full Text] [Related]
33. Catalytic properties of 26 S and 20 S proteasomes and radiolabeling of MB1, LMP7, and C7 subunits associated with trypsin-like and chymotrypsin-like activities.
Reidlinger J; Pike AM; Savory PJ; Murray RZ; Rivett AJ
J Biol Chem; 1997 Oct; 272(40):24899-905. PubMed ID: 9312091
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells.
Dick LR; Cruikshank AA; Destree AT; Grenier L; McCormack TA; Melandri FD; Nunes SL; Palombella VJ; Parent LA; Plamondon L; Stein RL
J Biol Chem; 1997 Jan; 272(1):182-8. PubMed ID: 8995245
[TBL] [Abstract][Full Text] [Related]
35. Reactions of [14C]-3,4-dichloroisocoumarin with subunits of pituitary and spleen multicatalytic proteinase complexes (proteasomes).
Orlowski M; Cardozo C; Eleuteri AM; Kohanski R; Kam CM; Powers JC
Biochemistry; 1997 Nov; 36(45):13946-53. PubMed ID: 9374874
[TBL] [Abstract][Full Text] [Related]
36. Evidence that the nature of amino acid residues in the P3 position directs substrates to distinct catalytic sites of the pituitary multicatalytic proteinase complex (proteasome).
Cardozo C; Vinitsky A; Michaud C; Orlowski M
Biochemistry; 1994 May; 33(21):6483-9. PubMed ID: 8204582
[TBL] [Abstract][Full Text] [Related]
37. The 2.0 A crystal structure and substrate specificity of the KDEL-tailed cysteine endopeptidase functioning in programmed cell death of Ricinus communis endosperm.
Than ME; Helm M; Simpson DJ; Lottspeich F; Huber R; Gietl C
J Mol Biol; 2004 Mar; 336(5):1103-16. PubMed ID: 15037072
[TBL] [Abstract][Full Text] [Related]
38. Lack of proteasome active site allostery as revealed by subunit-specific inhibitors.
Myung J; Kim KB; Lindsten K; Dantuma NP; Crews CM
Mol Cell; 2001 Feb; 7(2):411-20. PubMed ID: 11239469
[TBL] [Abstract][Full Text] [Related]
39. Arecoline tripeptide inhibitors of proteasome.
Marastoni M; Baldisserotto A; Canella A; Gavioli R; Risi CD; Pollini GP; Tomatis R
J Med Chem; 2004 Mar; 47(6):1587-90. PubMed ID: 14998343
[TBL] [Abstract][Full Text] [Related]
40. Proteasome inhibitors; synthesis and activity of arecoline oxide tripeptide derivatives.
Marastoni M; McDonald J; Baldisserotto A; Canella A; De Risi C; Pollini GP; Tomatis R
Bioorg Med Chem Lett; 2004 Apr; 14(8):1965-8. PubMed ID: 15050638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
